scispace - formally typeset
N

Neil Gibson

Researcher at European Union

Publications -  34
Citations -  2823

Neil Gibson is an academic researcher from European Union. The author has contributed to research in topics: Nanoparticle & Neutron. The author has an hindex of 16, co-authored 34 publications receiving 1998 citations.

Papers
More filters
Journal ArticleDOI

The Scherrer equation versus the 'Debye-Scherrer equation'

TL;DR: Paul Scherrer and Peter Debye developed powder X-ray diffraction together, but it was Scherrer who figured out how to determine the size of crystallites from the broadening of diffraction peaks.
Journal ArticleDOI

Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2

TL;DR: Since chronic, oral uptake of TiO2 particles by consumers has continuously increased in the past decades, the possibility of chronic accumulation of such biopersistent nanoparticles in secondary organs and the skeleton raises questions about the responsiveness of their defense capacities, and whether these could be leading to adverse health effects in the population at large.
Journal ArticleDOI

Radiolabelling of engineered nanoparticles for in vitro and in vivo tracing applications using cyclotron accelerators

TL;DR: An outline of some cyclotron-based irradiation techniques that can be used to directly radiolabel industrially manufactured nanoparticles, as well as two techniques for synthesis of labelled nanoparticles using cyclotrons-generated radioactive precursor materials.
Journal ArticleDOI

Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3

TL;DR: The biokinetics patterns after IT-instillation and GAV were similar but both were distinctly different from the pattern after intravenous injection disproving the latter to be a suitable surrogate of the former applications.
Journal ArticleDOI

Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1

TL;DR: The common hypothesis that IV-injection is a suitable predictor for the biokinetics fate of nanoparticles administered by different routes is disproved by this series of studies.